Sort   by:  
 Page size 
UnknownCirculating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma.
Not available
S-EPMC6205167 | biostudies-literature
UnknownLAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma.
Not available
S-EPMC7160288 | biostudies-literature
UnknownEBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.
Not available
S-EPMC6923667 | biostudies-literature
UnknownIntratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma.
Not available
S-EPMC8270658 | biostudies-literature
ProteomicsAbberant Cathepsin S Activity Modulates the Immune Microenvironment in Follicular Lymphoma
Tumor cells can induce their own advantageous microenvironment. Here, we describe aberrant cathepsin S (CTSS) activity to modulate T-cell activation in follicular lymphoma (FL). In donor-derived FLs following bone marrow transplantation, we identified independent acquisition of CTSS mutations at Y13...
ORGANISM(S): Homo sapiens (Human) 
2021-01-07 | PXD014612 | Pride
Cysteine-protease Hotspot mutations Immune signaling Hematology Follicular lymphoma 
UnknownIntra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.
Not available
S-EPMC11469944 | biostudies-literature
UnknownAdjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.
Not available
S-EPMC11663783 | biostudies-literature
Sort   by:  
 Page size